Biosergen, som utvecklar ett läkemedel för behandling av invasiva svampsjukdomar, har framgångsrikt ...
Idag den 4 april 2023 släppte Abelco bolagets kvartalsredogörelse för Q1-23 och givet att vår senast...
SaveLend förvärvar Lunars P2P verksamhet Lendify SaveLend förvärvar Lunars P2P verksamhet, som Lunar...
Redeye is optimistic about the continuing progress in the PFAS field for Lifeclean.
Fully secured SEK ~50m rights issue Enables expansion plans Implies post-money valuation of SEK ~125...
Redeye views positively the news that two Medicare Administrative Contractors (MACs) have updated th...
Mangold uppdaterar Twiik, utvecklaren av en digital träningsplattform.
Redeye comments on Zordix announcement that CEO Christina Seelye has increased her ownership in Zord...
Redeye sees the Q4 report from Coala Life boosting our confidence in the outlook for the company and...
Scandion Oncology has announced that the Phase Ib PANTAX trial has concluded and reached its primary...
Redeye har tagit del av BioArctics och dess partner Eisais vetenskapliga presentationer från konfere...
Q1 report due on Tuesday, 25 April Volatile weather should make for a soft quarter '23e trough earni...
Redeye comments on Cereno Scientific’s in-licensing agreement with CS585.
We expect a decent Q1 print driven by both divisions '23e-'25e adj.
Redeye is positive that NeoDynamics has shipped its CorePulse needles to 23 hospitals in the UK, Ger...
Marknadsföringsinvesteringar börjar bära frukt Nettoomsättningen i kvartalet uppgick till 96,1 mkr v...
Mantex, utvecklaren av röntgenprodukterna FlowScanner och Biofuel Analyzer, redovisade intäkter om 2...
Expect DKK 34m in sales and EBITDAC of DKK -19m 2023 will be an important year for product developme...
Several game signings of late, 20-40% sales growth guidance Increase in distribution capacity via Di...
Redeye provides an update to Wyld Networks Q4 2022 report.
